Mesoblast (MESO) EBT Margin Growth (3y) (2019 - 2023)
Mesoblast (MESO) EBT Margin Growth (3y) (2019 - 2023) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Mesoblast |
21.68 Bn |
21.55 Bn |
- |
- |
| Date | Value |
|---|
| Jun 30, 2023 |
54,625.00 |
| Mar 31, 2023 |
-13,424.00 |
| Dec 31, 2022 |
12,354.00 |
| Sep 30, 2022 |
-77,772.00 |
| Jun 30, 2022 |
58,190.00 |
| Mar 31, 2022 |
154,645.00 |
| Dec 31, 2021 |
116,454.00 |
| Sep 30, 2021 |
107,132.00 |
| Jun 30, 2021 |
17,712.00 |
| Mar 31, 2021 |
111,941.00 |
| Dec 31, 2020 |
-97,978.00 |
| Sep 30, 2020 |
-109,173.00 |
| Jun 30, 2020 |
538,590.00 |
| Dec 31, 2019 |
285,021.00 |
| Jun 30, 2019 |
-108,792.00 |
